Evidence map›Paper›PMID 40148481›Full record

ReviewBioprocess and biosystems engineering2025

Current strategies for rutin nano-formulation; a promising bioactive compound with increased efficacy.

Maryam Malekpour, Alireza Ebrahiminezhad, Zeinab Karimi, Mahdiyar Iravani Saadi, Aydin Berenjian

Abstract readReview
PubMed Publisher
In one paragraph

Review in Bioprocess and biosystems engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Comparative evaluation of quercetin, rutin, and their nanoparticles: enhanced antimicrobial and antioxidant activities.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maryam MalekpourDepartment of Medical Biotechnology, and Cellular and Molecular Research Center, Gerash University of Medical Sciences, Gerash, Iran.
Alireza EbrahiminezhadBiotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. a_ebrahimi@sums.ac.ir.
Zeinab KarimiDepartment of Medical Biotechnology, and Cellular and Molecular Research Center, Gerash University of Medical Sciences, Gerash, Iran.
Mahdiyar Iravani SaadiHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Aydin BerenjianDepartment of Chemical and Biological Engineering, Colorado State University, Fort Collins, CO, 80523, USA. aydin.berenjian@colostate.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rutin is an herbal polyphenolic compound recognized for its numerous therapeutic benefits, including antioxidant, anticancer, and antimicrobial properties. However, its application in biomedical fields encounters significant challenges, such as low solubility, poor absorption, low bioavailability, short half-life, and rapid metabolism. In recent years, advancements in nanotechnology have presented promising solutions to these limitations. Consequently, various nano-formulation strategies have been developed to enhance rutin's solubility, absorption, and overall efficacy. These strategies can be broadly categorized into two approaches. The first involves transforming rutin into nanocrystals without the use of any secondary compounds. The second approach entails nano-formulating rutin with other compounds, including proteins, polysaccharides, lipids, polymers, and metals. This study offers a review of these approaches and their applications in biomedical sciences, focusing on their categories, preparation methods, and biomedical properties. Initially, the pharmacological potential of rutin, its application in recent clinical trials, and its mechanisms of action are outlined. Next, it explores how nano-carriers can enhance rutin's bioavailability. Subsequently, the types of nanostructures employed are categorized, along with a discussion of their fabrication methods and benefits. In some instances, certain drawbacks are also reported. The data provided can guide the selection of optimal strategies for rutin nano-formulation, based on the intended biomedical application.

Indexed as

NanoparticlesRutinAnimalsAntioxidantsBiological AvailabilityHumansAntioxidantsRutinAnticancerAnti-inflammatoryAntimicrobialAntioxidantNano-carriersRutin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.